Insider Trading activities of 10x Genomics, Inc. (TXG)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of 10x Genomics, Inc. (TXG) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of 10x Genomics, Inc. since year 2005. Table 2 shows the detailed insider transactions of 10x Genomics, Inc. since 2005. The reporting company's ticker symbol is TXG. The reporting company's CIK number is 1770787.
The total value of stock buying since 2005 is $19,012,500.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for 10x Genomics, Inc. (TXG).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-09 487,500 $19,012,500 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of 10x Genomics, Inc. insiders (TXG)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-09-16 Roberts Bryan E (Director) Buy 300,000 39.00 11,700,000
2019-09-12 Tananbaum James B. (10% Owner) Buy 187,500 39.00 7,312,500

Insider trading activities including stock purchases, stock sales, and option exercises of TXG listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of 10x Genomics, Inc. (symbol TXG, CIK number 1770787) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month